Tavernier J - Search Results

1

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.

Cauwels A, Van Lint S, Garcin G, Bultinck J, Paul F, Gerlo S, Van der Heyden J, Bordat Y, Catteeuw D, De Cauwer L, Rogge E, Verhee A, Uzé G, Tavernier J. Cauwels A, et al. Among authors: tavernier j. Oncoimmunology. 2017 Nov 27;7(3):e1398876. doi: 10.1080/2162402X.2017.1398876. eCollection 2018. Oncoimmunology. 2017. PMID: 29399401 Free PMC article.

2

Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit.

Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R. Tavernier J, et al. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7041-5. doi: 10.1073/pnas.89.15.7041. Proc Natl Acad Sci U S A. 1992. PMID: 1495999 Free PMC article.

3

Expression of the murine interleukin-5 receptor on Xenopus laevis oocytes.

Devos R, Tavernier J, Plaetinck G, Van der Heyden J, Rolink A, Fiers W. Devos R, et al. Among authors: tavernier j. Biochem Biophys Res Commun. 1990 Oct 30;172(2):570-5. doi: 10.1016/0006-291x(90)90711-u. Biochem Biophys Res Commun. 1990. PMID: 1700706

4

Characterization of the murine IL-5 receptor complex with the use of a panel of monoclonal antibodies. Relationship to the murine IL-3 receptor.

Van der Heyden J, Devos R, Plaetinck G, Fache I, Fiers W, Tavernier J. Van der Heyden J, et al. Among authors: tavernier j. J Immunol. 1991 Nov 15;147(10):3413-8. J Immunol. 1991. PMID: 1940345

5

Amino acid sequence analysis of a mouse interleukin 5 receptor protein reveals homology with a mouse interleukin 3 receptor protein.

Devos R, Vandekerckhove J, Rolink A, Plaetinck G, Van der Heyden J, Fiers W, Tavernier J. Devos R, et al. Among authors: tavernier j. Eur J Immunol. 1991 May;21(5):1315-7. doi: 10.1002/eji.1830210533. Eur J Immunol. 1991. PMID: 2037015

6

Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.

Plaetinck G, Van der Heyden J, Tavernier J, Faché I, Tuypens T, Fischkoff S, Fiers W, Devos R. Plaetinck G, et al. Among authors: tavernier j. J Exp Med. 1990 Sep 1;172(3):683-91. doi: 10.1084/jem.172.3.683. J Exp Med. 1990. PMID: 2388031 Free PMC article.

7

Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction.

Cornelis S, Fache I, Van der Heyden J, Guisez Y, Tavernier J, Devos R, Fiers W, Plaetinck G. Cornelis S, et al. Among authors: tavernier j. Eur J Immunol. 1995 Jul;25(7):1857-64. doi: 10.1002/eji.1830250710. Eur J Immunol. 1995. PMID: 7542592

8

Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

Tavernier J, Tuypens T, Verhee A, Plaetinck G, Devos R, Van der Heyden J, Guisez Y, Oefner C. Tavernier J, et al. Proc Natl Acad Sci U S A. 1995 May 23;92(11):5194-8. doi: 10.1073/pnas.92.11.5194. Proc Natl Acad Sci U S A. 1995. PMID: 7761472 Free PMC article.

9

Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic disease.

Devos R, Plaetinck G, Cornelis S, Guisez Y, Van der Heyden J, Tavernier J. Devos R, et al. Among authors: tavernier j. J Leukoc Biol. 1995 Jun;57(6):813-9. doi: 10.1002/jlb.57.6.813. J Leukoc Biol. 1995. PMID: 7790761 Review.

10

Attenuation of allergic airway inflammation in IL-4 deficient mice.

Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H. Brusselle GG, et al. Among authors: tavernier jh. Clin Exp Allergy. 1994 Jan;24(1):73-80. doi: 10.1111/j.1365-2222.1994.tb00920.x. Clin Exp Allergy. 1994. PMID: 8156448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page